FOLD · As filed with the SEC

Amicus Therapeutics balance sheet, by quarter

The statement as Amicus Therapeutics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD thousands

USD thousands	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024
Assets
Current assets:
Cash and cash equivalents	214,010	190,553	158,702	181,657	213,752	233,647	209,335	209,761
Investments in marketable securities	79,526	73,290	72,296	68,916	36,194	16,110	50,727	29,842
Accounts receivable, net	115,307	113,838	105,849	88,323	101,099	98,073	85,174	76,433
Inventories, net	228,819	177,928	154,875	132,412	118,782	115,338	81,320	60,759
Prepaid expenses and other current assets	38,511	38,457	46,285	39,491	34,909	35,306	35,145	54,444
Total current assets	676,173	594,066	538,007	510,799	504,736	498,474	461,701	431,239
Operating lease right-of-use assets, net	21,138	21,549	21,988	22,138	22,278	23,144	22,611	23,003
Property and equipment, less accumulated depreciation of $31,821 and $28,775 at December 31, 2025 and 2024, respectively	27,108	27,759	28,570	28,718	29,383	30,438	31,161	32,421
Intangible assets, less accumulated amortization of $9,085 and $5,802 at December 31, 2025 and 2024, respectively	13,915	14,743	15,570	16,389	17,198	18,026	18,853	19,672
Goodwill	197,797	197,797	197,797	197,797	197,797	197,797	197,797	197,797
Other non-current assets	13,739	12,897	13,371	13,998	13,641	18,678	17,361	17,657
Total Assets	949,870	868,811	815,303	789,839	785,033	786,557	749,484	721,789
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	28,630	19,103	13,893	14,451	12,947	13,481	32,057	9,210
Accrued expenses and other current liabilities	200,457	171,165	145,144	129,877	127,300	136,116	127,897	124,622
Operating lease liabilities	8,741	8,662	8,610	8,562	8,455	8,541	8,112	8,270
Total current liabilities	237,828	198,930	167,647	152,890	148,702	158,138	168,066	142,102
Long-term debt	392,660	391,985	391,322	390,708	390,111	389,494	388,939	388,391
Operating lease liabilities	40,962	42,174	43,383	44,196	45,078	46,623	47,007	47,831
Other non-current liabilities	4,179	5,298	8,647	8,487	7,097	13,477	12,949	12,771
Total liabilities	675,629	638,387	610,999	596,281	590,988	607,732	616,961	591,095
Stockholders' equity:
Common stock, $0.01 par value, 500,000,000 shares authorized, 310,853,963 and 299,041,653 shares issued and outstanding at December 31, 2025 and 2024, respectively	3,037	3,017	3,016	3,016	2,944	2,942	2,923	2,922
Common stock in treasury, at cost; 7,390 shares as of December 31, 2025	(71)	(71)	(71)	(71)	—	—	—	—
Additional paid-in capital	3,014,456	2,973,625	2,956,839	2,939,673	2,926,115	2,905,760	2,868,925	2,853,550
Accumulated other comprehensive gain (loss):
Foreign currency translation adjustment	24,120	22,886	30,935	12,941	5,302	25,159	8,991	6,847
Unrealized loss on available-for-sale securities	(11)	(53)	(129)	(135)	(207)	(188)	(197)	(203)
Warrants	0	0	0	0	71	71	71	71
Accumulated deficit	(2,767,290)	(2,768,980)	(2,786,286)	(2,761,866)	(2,740,180)	(2,754,919)	(2,748,190)	(2,732,493)
Total stockholders' equity	274,241	230,424	204,304	193,558	194,045	178,825	132,523	130,694
Total Liabilities and Stockholders' Equity	949,870	868,811	815,303	789,839	785,033	786,557	749,484	721,789

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.

Data on this page was fetched Nov 5, 2026, 11:04 PM ET. The filing on SEC.gov is the record.